Literature DB >> 29803343

Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction.

Parin Shah1, Pierpaolo Pellicori2, Stella Rimmer2, Alan S Rigby2, Andrew L Clark2.   

Abstract

INTRODUCTION: We investigated whether increased concentrations of inspired oxygen (Fio2) affects exercise tolerance in patients with heart failure and normal ejection fraction (HeFNEF).
METHODS: 46 patients (mean age 75 years (63% male) and median NTproBNP 1432 (interquartile range: 543-2378 ng/l)) with HeFNEF (defined as signs or symptoms of heart failure requiring treatment with diuretics, with a left ventricular ejection fraction of >45% by echocardiography and amino terminal pro brain natriuretic peptide (NTproBNP) >220 ng/l) completed three maximal incremental exercise tests with different Fio2 (21%, 28% and 40%) in random order. Fio2 was controlled by investigator but blinded to patients. The primary outcome was exercise time (ET).
RESULTS: Increasing Fio2 significantly increased exercise time (522 ± 180 seconds for 21% to 543 ± 176 seconds, and 542 ± 177 seconds, for 28% and 40%, respectively, P = 0.04) with no difference in peak workload (57 ± 25 W, 58 ± 25 W and 57 ± 25 W, for 21%, 28% and 40%, respectively, P = 0.50). There was an increase in oxygen saturation but no change in peak heart rate with increasing Fio2. Compared to patients with LVEF ≥50%, patients with LVEF between 45 and 49% had a significantly greater exercise time and peak workload. There was a correlation between the difference in exercise time between Fio2 21% and 40% and age; but not with BMI, haemoglobin, creatinine or NTproBNP.
CONCLUSION: Increasing Fio2 during exertion leads to a small increase in exercise time in patients with HeFNEF.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Exercise; Heart failure with normal ejection fraction; Oxygen

Mesh:

Substances:

Year:  2018        PMID: 29803343     DOI: 10.1016/j.ijcard.2018.05.029

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  High vs. low oxygen therapy in patients with acute heart failure: HiLo-HF pilot trial.

Authors:  Nariman Sepehrvand; Wendimagegn Alemayehu; Brian H Rowe; Finlay A McAlister; Sean van Diepen; Michael Stickland; Justin A Ezekowitz
Journal:  ESC Heart Fail       Date:  2019-05-17

Review 2.  Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update.

Authors:  Pedro Vaz-Salvador; Rui Adão; Inês Vasconcelos; Adelino F Leite-Moreira; Carmen Brás-Silva
Journal:  Cardiovasc Drugs Ther       Date:  2022-01-31       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.